Noumi Ltd
ASX:NOU

Watchlist Manager
Noumi Ltd Logo
Noumi Ltd
ASX:NOU
Watchlist
Price: 0.12 AUD Market Closed
Market Cap: AU$33.3m

Noumi Ltd
Investor Relations

noumi Ltd. engages in the manufacture and sale of food products. The firm is engaged in manufacturing dairy and plant-based beverages, nutritional products and ingredients used across the health and fitness industries. The firm's segments include Dairy and Nutritionals, and Plant-based Beverages. The Dairy and Nutritionals segment includes a range of dairy milk beverages, nutritional products, and performance and adult nutritional powders, including the Crankt brand. Its Plant-based Beverages segment includes a range of beverage products, such as liquid stocks, soy, rice, oat and almond beverages. The firm operates manufacturing facilities in Victoria and New South Wales (NSW) and produces key brands, including the MILKLAB range of shelf-stable dairy and plant-based milks, Australia’s Own, So Natural, Crankt, Vital Strength, VITALIFE and PUREnFERRIN lactoferrin.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Feb 23, 2026
AI Summary
Q2 2026

EBITDA Growth: Adjusted operating EBITDA reached $33.9 million, up 23% from the first half of FY '25, reflecting strong execution and investment.

Record Plant-Based Sales: Plant-based milk segment delivered record revenue of $94.3 million, up 1.1%, with MILKLAB sales rising 11.1% and HORECA channel returning to growth.

Dairy & Nutritionals Turnaround: EBITDA for Dairy & Nutritionals more than doubled to $12.4 million, showing over 167% improvement, supported by higher bulk cream and export volumes.

Strategic Marketing Investment: Over $19 million invested in sales and marketing, mainly in plant-based milks, to support brand growth and innovation.

Statutory Loss: Statutory net loss after tax was $24.2 million, driven by a $42.2 million fair value adjustment on convertible notes.

Guidance on Costs: Marketing spend is expected to remain elevated in the near term but will moderate over time as growth investments mature.

Export Expansion: Strong export growth in both plant-based and dairy segments, with focus on Asia-Pacific markets, and some uplift from supply chain issues in the region.

Key Financials
Adjusted Operating EBITDA
$33.9 million
Revenue (Group)
$327 million
Revenue (Plant-Based Segment)
$94.3 million
EBITDA (Plant-Based)
$22.9 million
EBITDA (Dairy & Nutritionals)
$12.4 million
Statutory Net Loss After Tax
$24.2 million loss
Convertible Note Fair Value Adjustment
$42.2 million
MILKLAB Sales Growth
Up 11.1%
MILKLAB Lactose Free Growth
Up 16.9%
MILKLAB Oat Growth
Up 22.5%
HORECA Channel Sales Growth
Up 2.5%
Plant-Based Export Sales Growth
Up 18.4%
Bulk Cream Revenue
Up $8.3 million
Lactoferrin Volumes
Up 6.9%
Consumer Nutritionals Revenue
Up 2%
Vital Strength Growth
Up almost 8%
New Protein Growth
Up 11%
Net Cash from Trading
$23 million
Capital Expenditure
$2.5 million
Convertible Notes Carrying Value
$475 million
Total Debt
$662 million
Other Earnings Calls
2026
2023

Management

Mr. Michael R. Perich
CEO & MD
No Bio Available
Mr. Peter Myers CPA
Chief Financial Officer
No Bio Available
Mr. Stuart Muir
Chief Operations Officer
No Bio Available
Mr. Ash Peck
Acting Chief Information Officer
No Bio Available
Mr. Justin L. Coss ANZIIF CIP, B.A., Dip CII, FCIS, FGIA, L.L.B.
Group General Counsel & Company Secretary
No Bio Available
Mr. Gerard Smith
Chief Marketing Officer
No Bio Available
Ms. Tracy Hibbert
Chief People & Culture Officer
No Bio Available
Mr. Denise Phelps
Chief Customer Officer
No Bio Available
Mr. Michael Howard
Chief Transformation Officer
No Bio Available

Contacts

Address
NEW SOUTH WALES
80 Box Rd
Contacts
+61295262555.0
noumi.com.au
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett